Stock 4570 IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Immuno-Biological Laboratories Co., Ltd.

Equities

4570

JP3921300004

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-17 EDT 		5-day change 1st Jan Change
503 JPY +1.21% Intraday chart for Immuno-Biological Laboratories Co., Ltd. +5.89% +2.03%
2023 Immuno-Biological Laboratories Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
2023 An unknown buyer agreed to acquire unknown minority stake in CURED Co., Ltd. from Immuno-Biological Laboratories Co., Ltd. CI

Business Summary

Immuno-Biological Laboratories Co., Ltd. is a Japan-based company engaged in the research, development, manufacture and sales of pharmaceutical products and quasi-drugs. The Company operates in four business segments. The Diagnostic and Reagent segment is engaged in the manufacture, purchase and sales of research-related reagents, medicine, as well as vitro diagnostics. The Genetically Modified Silkworm segment is engaged in the sales of transgenic silkworm cocoons related products and research development of pharmaceutical raw materials. The Testing segment is engaged in the provision of support for prevention and diagnosis in addition to drug discovery and research support in the field of lifestyle-related diseases using lipid metabolism analysis technology. The Cosmetics segment is engaged in the sales of cosmetics and other products.

Number of employees: 60

Sales per Business

JPY in Million2022Weight2023Weight Delta
Antibody-Related
99.5 %
634 97.9 % 791 99.5 % +24.66%
Cosmetic Related
0.5 %
13 2.1 % 4 0.5 % -69.88%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
67.7 %
490 75.7 % 538 67.7 % +9.70%
United States
16.5 %
74 11.5 % 131 16.5 % +76.74%
Others
8.0 %
33 5.1 % 64 8.0 % +92.65%
Germany
7.7 %
50 7.7 % 61 7.7 % +23.50%

Managers

Managers TitleAgeSince
Tsutomu Seito PSD
 President 79 82-08-31
Masato Nakagawa ADM
 Chief Administrative Officer 61 07-09-30
Masahiro Maeda BRD
 Director/Board Member 66 94-03-31
Shoko Onodera BRD
 Director/Board Member 63 85-03-31

Members of the board

Members of the board TitleAgeSince
Tsutomu Seito PSD
 President 79 82-08-31
Shoko Onodera BRD
 Director/Board Member 63 85-03-31
Masahiro Maeda BRD
 Director/Board Member 66 94-03-31
Masato Nakagawa ADM
 Chief Administrative Officer 61 07-09-30
Kenji Fukunaga BRD
 Director/Board Member 54 10-05-31
Ikkei Kojima BRD
 Director/Board Member 41 19-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 9,314,590 7,494,658 ( 80.46 %) 1,132 ( 0.0122 %) 80.46 %

Shareholders

NameEquities%Valuation
Tsutomu Seito
12.06 %
1,123,700 12.06 % 3 M ¥
Rahim Barati
2.255 %
210,000 2.255 % 627 205 ¥
TRANS GENIC INC.
2.201 %
205,000 2.201 % 612 271 ¥
Akira Hoshikawa
1.621 %
151,000 1.621 % 450 990 ¥
Kazumi Nakazawa
1.091 %
101,600 1.091 % 303 448 ¥
THE TOWA BANK, LTD.
1.074 %
100,000 1.074 % 298 669 ¥
Shoko Onodera
0.5368 %
50,000 0.5368 % 149 335 ¥
Masahiro Maeda
0.1589 %
14,800 0.1589 % 44 203 ¥
Masato Nakagawa
0.1041 %
9,700 0.1041 % 28 971 ¥
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
0.0118 %
1,100 0.0118 % 3 285 ¥

Holdings

NameEquities%Valuation
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD.
0.01%
 1,100 0.01% 3,285 $

Company contact information

Immuno-Biological Laboratories Co., Ltd.

1091-1 Naka Aza-Higashida

375-0005, Fujioka

+

http://www.ibl-japan.co.jp
address Immuno-Biological Laboratories Co., Ltd.(4570)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. Stock Immuno-Biological Laboratories Co., Ltd.
+2.03% 29.81M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.07% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+29.39% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.75% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.95% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.87% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.25% 239B
ROCHE HOLDING AG Stock Roche Holding AG
-3.03% 209B
NOVARTIS AG Stock Novartis AG
+10.02% 209B
AMGEN INC. Stock Amgen Inc.
+7.93% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4570 Stock
  4. Company Immuno-Biological Laboratories Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW